The high expression of SLC39A6 is a dependable marker for breast cancer (luminal A subtype), and elevated SLC39A10 mRNA levels were evident in the cancer cell lines of the highly aggressive breast cancer (Kagara et al., 2007; Hogstrand et al., 2013). Here, SLC39A6 is linked to cancer.